Nureca (NURECA): Company Update
Company Update Nureca Limited has informed the exchange regarding the Investor Presentation. Nureca Limited has informed the exchange regarding the Investor Presentation.
Company Update Nureca Limited has informed the exchange regarding the Investor Presentation. Nureca Limited has informed the exchange regarding the Investor Presentation.
Result Audited Financial Results along with Audit Report for the quarter and year ended March 31, 2026 is attached. Audited Financial Results along with Audit Report for the quarter and year ended March 31, 2026 is attached.
Result Audited Financial Results along with Audit Report for the quarter and year ended March 31, 2026 is attached. Audited Financial Results along with Audit Report for the quarter and year ended March 31, 2026 is attached.
Result Audited Financial Results along with Audit Report for the quarter and year ended March 31, 2026 is attached. Audited Financial Results along with Audit Report for the quarter and year ended March 31, 2026 is attached.
Board Meeting Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith. Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith.
Board Meeting Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith. Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith.
Board Meeting Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith. Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith.
Outcome of Board Meeting Lovable Lingerie Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Lovable Lingerie Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Lovable Lingerie Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Lovable Lingerie Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Lovable Lingerie Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Lovable Lingerie Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.